Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Industrial Goods — Chemicals. Per the activity note to the FY2024 annual report, the company carries out wholesale trade in chemical products.
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 11.6% | 6.7% | 11.0% | 10.0% | 8.7% |
| EBITDA Margin | 7.8% | 2.5% | 6.7% | 6.2% | 7.1% |
| EBITDAR | 417 | 456 | 1,042 | 1,032 | 845 |
| EBITDAR Margin | 8.5% | 3.8% | 8.1% | 7.5% | 7.4% |
| EBIT Margin | 7.4% | 2.1% | 6.2% | 5.9% | 6.6% |
| Net Profit Margin | 9.0% | 1.1% | 5.5% | 7.4% | 3.7% |
| Operating Expense % of Sales | 3.9% | 4.2% | 4.4% | 3.7% | 1.6% |
| Returns | |||||
| Return on Assets (ROA) | 20.0% | 2.4% | 7.3% | 9.9% | 3.7% |
| Return on Equity (ROE) | 46.4% | 12.6% | 20.5% | 23.7% | 9.0% |
| ROIC [EBIT / Invested Capital] | 39.1% | 7.8% | 11.6% | 11.3% | 8.8% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 0.1% | 40.1% | 37.5% | 28.3% | 34.0% |
| Debt-to-Equity | 0.00x | 2.07x | 1.04x | 0.68x | 0.82x |
| Debt-to-EBITDA | 0.00x | 7.27x | 4.19x | 3.41x | 4.82x |
| Equity-to-Assets | 43.0% | 19.4% | 35.9% | 41.6% | 41.6% |
| Net Debt | -13 | 2,144 | 3,485 | 2,823 | 3,828 |
| Cash & Equivalents | 15 | 9 | 86 | 102 | 31 |
| Total Debt | 1 | 2,153 | 3,570 | 2,924 | 3,859 |
| Liquidity & working capital | |||||
| Current Ratio | 0.09x | 2.38x | 3.70x | 3.30x | 4.08x |
| Quick Ratio | -0.97x | 0.58x | 3.70x | 3.30x | 4.08x |
| Cash Ratio | 0.01x | 0.00x | 0.03x | 0.03x | 0.01x |
| Total Current Assets | 114 | 5,161 | 9,369 | 10,215 | 11,300 |
| Total Current Liabilities | 1,248 | 2,172 | 2,535 | 3,098 | 2,773 |
| Inventory | 1,320 | 3,910 | N/A | N/A | N/A |
| Trade Receivables | 277 | 523 | 492 | 495 | 2,539 |
| Trade Payables | 299 | 1,089 | 2,533 | 2,441 | 2,114 |
| Net Working Capital | -1,134 | 2,989 | 6,834 | 7,117 | 8,527 |
| Net Working Capital % of Revenue | -23.2% | 25.0% | 53.3% | 51.7% | 75.1% |
| Trade Working Capital | 1,297 | 3,344 | -2,041 | -1,946 | 425 |
| Trade Working Capital % of Revenue | 26.5% | 28.0% | -15.9% | -14.1% | 3.7% |
| Change in Trade Working Capital | N/A | 2,048 | -5,385 | 95 | 2,371 |
| Turnover & efficiency | |||||
| Inventory Turnover | 3.27x | 2.85x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 111.5 | 128.0 | N/A | N/A | N/A |
| Receivables Turnover | 17.67x | 22.85x | 26.05x | 27.79x | 4.47x |
| Days Sales Outstanding (DSO) | 20.7 | 16.0 | 14.0 | 13.1 | 81.7 |
| Payables Turnover | 14.42x | 10.24x | 4.50x | 5.07x | 4.90x |
| Days Payable Outstanding (DPO) | 25.3 | 35.6 | 81.1 | 71.9 | 74.5 |
| Cash Conversion Cycle | 106.9 days | 108.4 days | -67.1 days | -58.8 days | 7.2 days |
| Asset Turnover | 2.23x | 2.23x | 1.35x | 1.33x | 1.00x |
| Cash flow & dividends | |||||
| Operating Cash Flow | -756 | -1,875 | -2,875 | 793 | 24 |
| Free Cash Flow (OCF − Capex proxy) | -885 | -1,945 | -2,877 | 792 | 24 |
| Cash Conversion (OCF / EBITDA) | -199.3% | -633.2% | -337.0% | 92.4% | 3.0% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →